• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原癌基因ret在人类嗜铬细胞瘤和甲状腺髓样癌中持续表达。

The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.

作者信息

Santoro M, Rosati R, Grieco M, Berlingieri M T, D'Amato G L, de Franciscis V, Fusco A

机构信息

Centro di Endocrinologia ed Oncologia Sperimentale del CNR, II Facoltà di Medicina e Chirurgia, Università di Napoli, Italy.

出版信息

Oncogene. 1990 Oct;5(10):1595-8.

PMID:1701232
Abstract

We have recently reported the identification of a new oncogene, named PTC, frequently activated in human thyroid papillary carcinomas. This gene is a novel rearranged form of the ret proto-oncogene and we have shown that this rearrangement occurred in vivo as a tumor-specific somatic event. In an effort to further examine the role of this oncogene in human malignancies, we have investigated the expression of the ret oncogene in a number of human tumors. We consistently detected expression of normal-sized transcripts of the ret proto-oncogene in human pheochromocytomas and in human medullary thyroid carcinomas (MTC), both of familial and sporadic type. Moreover, we showed that ret mRNA levels were increased following (Bu)2cAMP-induced differentiation of a human MTC cell line (TT). Since the ret gene has been mapped on chromosome 10, close to the gene which predisposes patients to the MEN2A syndrome, we suggest that this region of chromosome 10 might be involved in the proliferative and differentiative patterns of these neuroectodermal tissues.

摘要

我们最近报告了一种新的癌基因的鉴定,该基因名为PTC,在人类甲状腺乳头状癌中经常被激活。这个基因是原癌基因ret的一种新的重排形式,并且我们已经表明这种重排作为一种肿瘤特异性体细胞事件在体内发生。为了进一步研究这种癌基因在人类恶性肿瘤中的作用,我们研究了ret原癌基因在多种人类肿瘤中的表达。我们在人类嗜铬细胞瘤和家族性及散发性的人类甲状腺髓样癌(MTC)中持续检测到ret原癌基因正常大小转录本的表达。此外,我们表明,在(Bu)2cAMP诱导的人类MTC细胞系(TT)分化后,ret mRNA水平升高。由于ret基因已定位于10号染色体,靠近使患者易患MEN2A综合征的基因,我们认为10号染色体的这个区域可能参与了这些神经外胚层组织的增殖和分化模式。

相似文献

1
The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.原癌基因ret在人类嗜铬细胞瘤和甲状腺髓样癌中持续表达。
Oncogene. 1990 Oct;5(10):1595-8.
2
Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
Henry Ford Hosp Med J. 1992;40(3-4):215-9.
3
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.1995年鲁道夫·魏尔啸奖。RET原癌基因突变分析在2型多发性内分泌腺瘤病(MEN 2)基因携带者诊断以及散发性和家族性甲状腺髓样癌与嗜铬细胞瘤鉴别中的作用
Verh Dtsch Ges Pathol. 1995;79:L-LV.
4
Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method.采用逆转录聚合酶链反应(RT-PCR)方法检测甲状腺腺瘤和腺瘤性甲状腺肿中的retTPC/PTC转录本。
Oncogene. 1991 Sep;6(9):1667-72.
5
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.人类甲状腺肿瘤中Ret原癌基因的激活仅限于乳头状癌亚型。
J Clin Invest. 1992 May;89(5):1517-22. doi: 10.1172/JCI115743.
6
Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.在神经母细胞瘤细胞系及MEN2A患者的甲状腺髓样癌中对ret原癌基因启动子区域的鉴定与分析。
Oncogene. 1992 Jun;7(6):1201-6.
7
RET proto-oncogene mutations and rearrangements in endocrine diseases.内分泌疾病中的RET原癌基因突变与重排
Am J Pathol. 1995 Dec;147(6):1539-44.
8
The RET proto-oncogene in sporadic pheochromocytomas.散发性嗜铬细胞瘤中的RET原癌基因。
Intern Med. 1996 Jun;35(6):449-52. doi: 10.2169/internalmedicine.35.449.
9
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.甲状腺髓样癌和嗜铬细胞瘤中c-mos原癌基因及内皮素B受体基因的突变分析
Br J Cancer. 1996 Aug;74(3):339-41. doi: 10.1038/bjc.1996.363.
10
Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.通过原位杂交检测人甲状腺乳头状癌中RET癌基因的激活
Br J Cancer. 1992 Dec;66(6):1094-8. doi: 10.1038/bjc.1992.416.

引用本文的文献

1
Tumour microenvironment in pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤的肿瘤微环境。
Front Endocrinol (Lausanne). 2023 Mar 22;14:1137456. doi: 10.3389/fendo.2023.1137456. eCollection 2023.
2
Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.超级增强子控制的正反馈回路 BRD4/ERα-RET-ERα 促进了 ERα 阳性乳腺癌的发生。
Nucleic Acids Res. 2022 Oct 14;50(18):10230-10248. doi: 10.1093/nar/gkac778.
3
RET signaling pathway and RET inhibitors in human cancer.人类癌症中的RET信号通路与RET抑制剂
Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022.
4
Late-Onset Medullary Thyroid Cancer in a Patient with a Germline Codon C634R Mutation.一名携带种系密码子C634R突变患者的迟发性甲状腺髓样癌
Diagnostics (Basel). 2021 Aug 11;11(8):1448. doi: 10.3390/diagnostics11081448.
5
MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives.《甲状腺髓样癌中的 microRNAs:调控机制及未来展望的综述》
Cells. 2021 Apr 20;10(4):955. doi: 10.3390/cells10040955.
6
Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations.带有 SDHx、VHL 或 MAML3 基因突变的副神经节瘤的主调控因子分析。
BMC Cancer. 2019 Jun 24;19(1):619. doi: 10.1186/s12885-019-5813-z.
7
Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies.波纳替尼:一种新型的抗人类恶性肿瘤的多酪氨酸激酶抑制剂。
Onco Targets Ther. 2019 Jan 18;12:635-645. doi: 10.2147/OTT.S189391. eCollection 2019.
8
A Review of Driver Genetic Alterations in Thyroid Cancers.甲状腺癌驱动基因改变综述
Iran J Pathol. 2018 Spring;13(2):125-135. Epub 2018 Jul 17.
9
Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.从遗传和表观遗传学角度看多发性内分泌肿瘤综合征
Biomark Insights. 2018 Jul 2;13:1177271918785129. doi: 10.1177/1177271918785129. eCollection 2018.
10
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.系统表面组学分析鉴定了晚期前列腺癌亚型免疫治疗的靶抗原。
Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4473-E4482. doi: 10.1073/pnas.1802354115. Epub 2018 Apr 23.